Methocarbamol And Aspirin
NDC Package 50564-490-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Methocarbamol And Aspirin is tablets are indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. Marketed by Jerome Stevens Pharmaceuticals, Inc., this product is identified by NDC 50564-490 and is authorized under FDA application ANDA081145.

Identification & Billing

NDC Package Code
50564-490-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
50564-490
11-Digit Billing Format
50564049001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Methocarbamol And Aspirin
Dosage Form
-
Usage Information
Methocarbamol and Aspirin tablets are indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Regulatory & Marketing

Labeler Name
Jerome Stevens Pharmaceuticals, Inc.
FDA Application #
ANDA081145
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-31-1995
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50564-490). Click a package code to view its specific billing and regulatory data.

50564-490-05
500 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50564-490-01 identifies a specific commercial package of 100 tablet in 1 bottle of Methocarbamol And Aspirin, labeled by Jerome Stevens Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Jerome Stevens Pharmaceuticals, Inc. on January 31, 1995. The current certification is valid through December 31, 2025.

How is this Jerome Stevens Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50564049001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50564-490-01
11-Digit CMS (5-4-2)
50564-0490-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.